$SG

Sweetgreen cuts full-year outlook as cyclospora fears weigh on sales

Sweetgreen cut its 2026 outlook, citing reduced consumer demand for fresh prepared foods amid the ongoing cyclospora outbreak. The company now expects same-store sales to fall 7% to 8%, versus a prior 2% to 4%, and projects adjusted EBITDA loss of $27 million to $23 million. Sweetgreen says it is not implicated; the FDA points to iceberg lettuce from a Taylor Farms facility in Mexico.

Original reporting
Published Aug 6, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sweetgreen cuts full-year outlook as cyclospora fears weigh on sales — source image
Decision brief

The 30-second read

$SGBearishHigh
01

Why it matters

The company attributes weaker demand to diner fears of eating fresh produce and updates both same-store sales and adjusted EBITDA loss expectations for 2026.

02

Market read

This is a direct company guidance reset tied to a food-safety shock, with immediate market repricing signaled by a >15% extended-trading drop.

03

What to watch

The article notes Sweetgreen is not implicated, so the magnitude may depend more on consumer perception and media coverage than on actual product exposure.

Relevance 9/10Novelty 9/10Timing: after-hours guidance cut and extended-trading selloff on Aug 6

Background

Sweetgreen is facing a cyclospora outbreak that has sickened at least 10,000 people, with FDA pointing to iceberg lettuce from a Taylor Farms facility in central Mexico.

Company-level read

Ticker impact

$SGBearishHigh confidence
Context

Sweetgreen cut its 2026 outlook, projecting same-store sales declines of 7% to 8% versus prior 2% to 4% due to cyclospora fears.

Expected impact

Further downside risk if consumer recovery timing stays uncertain and fresh outbreak headlines persist.

Evidence & confidence

The article discloses a concrete full-year guidance cut tied directly to reduced consumer demand, with shares already down more than 15% in extended trading.

Market effects

Food-safety fear can quickly reset demand for fresh-prepared food categories, raising volatility for salad and quick-service peers.

Primarily US consumer demand impact given CDC/FDA outbreak framing and nationwide chain references.

Limited direct global relevance, but it highlights cross-border supply-chain contamination risk for food retailers.

Counterpoint

If the outbreak is contained and recalls are effective, the demand hit may be temporary, making the guidance cut overly conservative.

Key entities

  • Sweetgreen

    US salad chain cutting full-year outlook due to cyclospora-related consumer demand fears.

  • Centers for Disease Control and Prevention

    CDC data cited for outbreak scale and fatalities.

  • Food and Drug Administration

    FDA cited as pointing to iceberg lettuce from a Taylor Farms facility and issuing recalls.

  • Yum Brands

    Taco Bell is described as the only nationwide restaurant chain linked to the outbreak, with sales bounce-back.

  • Chipotle Mexican Grill

    Said cyclospora fears had about a 2 percentage point impact on sales in late July’s second-half period.

Related articles

$SGMedAI 8/10

Sweetgreen Stumbles Again. Are the Turnaround Chances Gone?

Sweetgreen (NYSE: SG) reported another weak quarter after hours, with shares down double digits before partially recovering. Same-store sales decline narrowed to 6.2% in Q2 from 12.8% in Q1, but a cyclospora outbreak hurt July comps, cutting full-year guidance to same-store sales down 7%-8% and adjusted EBITDA loss of $23M-$27M. Management cited improving throughput and wrap adoption.

$SGHighAI 9/10

Why Sweetgreen Stock Tumbled Today

Sweetgreen (SG) shares fell after the company missed Q2 estimates and cut full-year guidance, citing a cyclospora outbreak impact on demand even though it said it was not directly affected. Same-store sales fell 6.2% and revenue rose 3.8% to $192.7M. Restaurant margin and adjusted EBITDA deteriorated, and GAAP loss per share widened to $0.22.

$SGMedAI 8/10

Sweetgreen Q2 2026 Loss Deepens:

Sweetgreen (NYSE:SG) reported Q2 2026 results that missed consensus. Diluted loss was $0.22 per share, 83.3% worse than the $0.12 loss estimate. Revenue was $192.7M, slightly below the $194.9M forecast. Net loss was $26.3M, same-store sales fell 6.2%, and shares dropped 3.8% to $5.87.

$SGHighAI 9/10

Sweetgreen Stock Slides Friday: What's Driving the Action? - Sweetgreen (NYSE:SG)

Sweetgreen (NYSE:SG) shares fell about 9.7% in premarket after Q2 results missed expectations. The company reported a net loss of 22 cents per share versus a 14 cent loss estimate, with revenue of $192.66 million below $194.90 million. Same-store sales declined 6.2%, and restaurant profit margin fell to 13.1%. Sweetgreen cut its 2026 outlook, citing weaker demand after a cyclosporiasis outbreak; TD Cowen lowered its price target to $5 from $8.

$SGHighAI 9/10

Sweetgreen revised its 2026 same-store sales outlook to a 7% to 8% decline, down from a prior 2% to 4% forecast,…

Sweetgreen revised its 2026 same-store sales outlook to a 7% to 8% decline, down from a prior 2% to 4% forecast, citing weaker demand for fresh prepared foods after a multistate cyclosporiasis outbreak. The company said cyclospora headlines disrupted momentum from mid-July, with July comparable sales down about 600 bps. Sweetgreen reported Q2 same-store sales down 6.2% and guided FY adjusted EBITDA loss of $27m to $23m.